StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$50.78−0.68 (-1.32%)

Close on Nov 20, 2026Market cap $7.06BP/E –Yield –

Cytokinetics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Cytokinetics

Cytokinetics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cytokinetics figures

See a number that looks wrong?